Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients

Diabetes and Vascular Disease Research

Volumn 10, Issue 5, 2013, Pages 420-425

  Savić, Vedran ^a   Eržen, Barbara ^a   Janić, Miodrag ^a   Lunder, Mojca ^a   Boncelj, Maja ^a   Kanc, Karin ^b   Janež, Andrej ^a   Šabovič, Mišo ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Diabetes and Me Private Diabetes Centre   (Slovenia)

Author keywords

cardiovascular prevention; fluvastatin and valsartan combination; low dose; Type 1 diabetes mellitus

Indexed keywords

FLUINDOSTATIN; VALSARTAN;

ADULT; ARTERIAL STIFFNESS; ARTERY WALL; ARTICLE; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MALE; PULSE WAVE; TREATMENT DURATION;

CARDIOVASCULAR PREVENTION; FLUVASTATIN AND VALSARTAN COMBINATION; LOW DOSE; TYPE 1 DIABETES MELLITUS;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTICHOLESTEREMIC AGENTS; BLOOD PRESSURE; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 84882421466     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113485102     Document Type: Article

References (25)

1. Astrup AS. Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis. Dan Med Bull. 2011 ; 58: B4152
2. Bollyky J, Sanda S, Greenbaum CJ. Type 1 diabetes mellitus: primary, secondary, and tertiary prevention. Mt Sinai J Med. 2008 ; 75: 385-397
3. Christen AI, Armentano RL, Miranda A, et al. Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings. Curr Diabetes Rev. 2010 ; 6: 367-377
4. Cameron JD, Cruickshank JK. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol. 2007 ; 34: 677-682
5. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007 ; 3: 853-876
6. Tousoulis D, Tsarpalis K, Cokkinos D, et al. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications. Diabetes Obes Metab. 2008 ; 10: 834-842
7. Rahman S, Rahman T, Ismail AA, et al. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007 ; 9: 767-780
8. Schram MT, Chaturvedi N, Fuller JH, et al. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. J Hypertens. 2003 ; 21: 2035-2044
9. Benetos A. Pulse pressure and arterial stiffness in type 1 diabetic patients. J Hypertens. 2003 ; 21: 2005-2007
10. Lunder M, Janic M, Habjan S, et al. Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males - a pilot study. Atherosclerosis. 2011 ; 215: 446-451
11. Lunder M, Janic M, Sabovic M. Reduction of age-associated arterial wall changes by low-dose valsartan. Eur J Prev Cardiol. 2012 ; 19: 1243-1249
12. Lunder M, Janic M, Jug B, et al. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial. Eur J Intern Med. 2012 ; 23: 261-266
13. Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 2010 ; 18: 298-304
14. Jankowski P, Safar ME, Benetos A. Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system. Curr Pharm Des. 2009 ; 15: 571-584
15. Ii M, Losordo DW. Statins and the endothelium. Vascul Pharmacol. 2007 ; 46: 1-9
16. Faggiotto A, Paoletti R. State-of-the-art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action. Hypertension. 1999 ; 34: 987-996
17. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002 ; 39: 257-265
18. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 ; 340: 1111-1115
19. Mullen MJ, Wright D, Donald AE, et al. Atorvastatin but not l-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Coll Cardiol. 2000 ; 36: 410-416
20. Dogra GK, Watts GF, Chan DC, et al. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabet Med. 2005 ; 22: 239-242
21. Konduracka E, Galicka-Latala D, Cieslik G, et al. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension. Diabetes Obes Metab. 2008 ; 10: 719-725
22. Tomizawa A, Hattori Y, Suzuki K, et al. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin. Int J Cardiol. 2010 ; 144: 108-109
23. Karalliedde J, Smith A, DeAngelis L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension. 2008 ; 51: 1617-1623
24. Kim JH, Oh SJ, Lee JM, et al. The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension. Diabetes Metab J. 2011 ; 35: 236-242
25. Lunder M, Janic M, Ziberna L, et al. A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts. Med Sci Monit. 2012 ; 18: 366-374